Curaleaf Holdings (CURLF) Finished Goods (2019 - 2022)
Curaleaf Holdings (CURLF) posted quarterly Finished Goods of $74.3 million for Q4 2022, up 3.73% year-on-year from $71.6 million in Q4 2021, and up 3.73% on a QoQ basis from $71.6 million in Q4 2021.
Curaleaf Holdings (CURLF) Finished Goods (2019 - 2022) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Finished Goods for 4 consecutive years, with $74.3 million the latest figure, recorded in Q4 2022.
- Quarterly Finished Goods rose 3.73% year-over-year to $74.3 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $74.3 million (up 3.73% YoY) and the FY2021 annual result came in at $71.6 million, up 88.04% from the prior year.
- Finished Goods rose to $74.3 million in Q4 2022 per CURLF's latest filing, from $71.6 million in the prior quarter.
- Over the last five years, Finished Goods for CURLF reached as high as $74.3 million in Q4 2022 and fell as low as $27.0 million in Q4 2019.
- A 4-year average of $52.8 million and a median of $54.9 million in 2020 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2021 — Finished Goods soared 88.04% — and 2022, when it rose 3.73%.
- Year by year, Finished Goods stood at $27.0 million in 2019, then jumped by 41.16% to $38.1 million in 2020, then jumped by 88.04% to $71.6 million in 2021, then increased by 3.73% to $74.3 million in 2022.
- According to Business Quant data, Finished Goods over the past three periods registered $74.3 million, $71.6 million, and $38.1 million for Q4 2022, Q4 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 74.32 Mn |
| Dec 31, 2021 | 71.65 Mn |
| Dec 31, 2020 | 38.10 Mn |
| Dec 31, 2019 | 26.99 Mn |